Clinical Trial Detail

NCT ID NCT02234596
Title Nintedanib in Patients With Advanced Esophagogastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Nintedanib

Age Groups: adult

Additional content available in CKB BOOST